Integra sees 2.4% Q1 revenue growth to $391.9M and names new CEO
Integra reported Q1 2026 revenues of $391.9 million, up 2.4% reported and 1.3% organic, with adjusted EPS rising to $0.54 from $0.41. The company reaffirmed full-year revenue guidance at $1.662–1.702 billion and updated adjusted EPS guidance to $2.40–2.50, while appointing Stuart Essig as president and CEO and Michael McBreen as chief commercial officer.
1. First Quarter Financial Results
Integra reported Q1 2026 revenues of $391.9 million, up 2.4% on a reported basis and 1.3% organically. GAAP gross margin improved to 55.4% and adjusted gross margin rose to 64.1%, delivering adjusted EBITDA of $76.2 million (19.4% of revenue) and adjusted EPS of $0.54.
2. Full-Year Guidance and Profit Outlook
The company reaffirmed 2026 revenue guidance at $1.662–1.702 billion, representing 1.6–4.1% reported growth, and updated adjusted EPS guidance to $2.40–2.50 per share after accounting for IEEPA tariff benefits. Second-quarter revenue is projected at $410–425 million with adjusted EPS of $0.44–0.52.
3. Executive Leadership Transition
Stuart M. Essig, chair since 2012 and former CEO from 1997 to 2012, has been appointed president and CEO effective May 1, 2026, while retaining his chairmanship. Michael McBreen, previously EVP and president of Codman Specialty Surgical, becomes chief commercial officer to centralize global commercial operations and drive revenue growth.